Uncategorized Imbruvica (Ibrutinib): Targeted Therapy for CLL and Lymphoma. For decades, patients diagnosed with B-cell blood cancers like chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphomas relied almost exclusively on Read More July 22, 2026